Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Gulf Pharmaceutical Industries PSC's Dividend Yield % or its related term are showing as below:
During the past 13 years, the highest Dividend Yield of Gulf Pharmaceutical Industries PSC was 7.44%. The lowest was 0.00%. And the median was 4.98%.
ADX:JULPHAR's Dividend Yield % is not ranked *
in the Medical Distribution industry.
Industry Median: 2.81 * Ranked among companies with meaningful Dividend Yield % only.
During the past 13 years, the highest Dividend Payout Ratio of Gulf Pharmaceutical Industries PSC was 1.80. The lowest was 0.55. And the median was 1.18.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Gulf Pharmaceutical Industries PSC was 30.40% per year. The lowest was -10.70% per year. And the median was 14.80% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ADX:JULPHAR vs MCK, CAH, COR: Dividend Yield % Comparison
For the Medical Distribution subindustry, Gulf Pharmaceutical Industries PSC's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gulf Pharmaceutical Industries PSC Dividend Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Gulf Pharmaceutical Industries PSC's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Gulf Pharmaceutical Industries PSC's Dividend Yield % falls into.
Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) has a Dividend Yield % of 0.00% as of Jul. 24, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Gulf Pharmaceutical Industries PSC and its competitors. According to the industry distribution chart, Gulf Pharmaceutical Industries PSC ranks #999999 out of 68 companies in the Medical Distribution industry.
Is Gulf Pharmaceutical Industries PSC's Dividend Yield % too high?
Gulf Pharmaceutical Industries PSC's current Dividend Yield % is 0.00%. Based on the distribution chart, Gulf Pharmaceutical Industries PSC ranks #999999 out of 68 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Gulf Pharmaceutical Industries PSC has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Gulf Pharmaceutical Industries PSC's Dividend Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Gulf Pharmaceutical Industries PSC ranks #999999 out of 68 companies for Dividend Yield %. This places Gulf Pharmaceutical Industries PSC in the lower half of its industry. The industry median Dividend Yield % is 2.81. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Distribution company?
The median Dividend Yield % among Medical Distribution companies is 2.81, based on 68 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Gulf Pharmaceutical Industries PSC and its competitors. For the Medical Distribution industry, the median Dividend Yield % is 2.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gulf Pharmaceutical Industries PSC's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gulf Pharmaceutical Industries PSC stock overvalued right now?
Based on GuruFocus' analysis, Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) is currently considered Fairly Valued. The stock's GF Value™ is د.إ1.09, compared to a current price of د.إ1.04 — trading 4.6% below its estimated fair value. The current Dividend Yield % is 0.00%. Gulf Pharmaceutical Industries PSC's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Gulf Pharmaceutical Industries PSC (ADX:JULPHAR), the current Dividend Yield % is 0.00% as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Overvalued in 2026?
Based on GuruFocus' analysis, Gulf Pharmaceutical Industries PSC stock appears to be undervalued.
The current stock price of د.إ1.04 is trading 4.6% below its estimated GF Value™ of د.إ1.09.
GuruFocus considers Gulf Pharmaceutical Industries PSC to be Fairly Valued.
Key valuation signals for ADX:JULPHAR:
Dividend Yield %: 0.00%
GF Value™: د.إ1.09 vs. price of د.إ1.04 (4.6% below fair value)
No single metric tells the full story. See the ADX:JULPHAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gulf Pharmaceutical Industries PSC Business Description
Gulf Pharmaceutical Industries PSC is in the business of manufacturing and selling medicines, drugs, and various other types of pharmaceutical and medical compounds in addition to cosmetic compounds. The company operates in four segments: Manufacturing, Trading, Investments, and others. The majority of its revenue is generated from the Manufacturing segment. The geographical segments are UAE, Other GCC countries, and Other countries. It derives maximum revenue from UAE. Its business is centered around General Medicines in the retail pharmacy channel and hospitals as well as speciality Products. Its medicines also targets therapeutic segments such as Diabetes, Gastrointestinal Tract (GIT), Respiratory, Wounds and Scars, Anti-infectives, Anemia, Gynecology, Erectile Dysfunction and Others.
54GF Score
Get the complete analysis for ADX:JULPHAR
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADX:JULPHAR has been successfully added to your 
